Friday, January 27, 2012
Stroke is one of the most common causes of death in the U.S. and Europe. However, due improved emergency and recovery strategies, an increasing number of stroke victims survive – albeit with serious long-term disabilities. Current treatments for stroke-related vision and speech impairment mainly involve long-term individual training, such as physical, speech, and ergo-therapy. EBS Technologies GmbH, near Berlin, recently developed the EBS NEXT WAVE™ therapy, an approach that fills a great medical need as there are few therapeutic solutions for treating disabilities incurred after stroke and brain trauma.
The EBS NEXT WAVE™ therapy is a non-invasive electrical brain stimulation device that activates residual brain structures through the enhancement of synaptic transmission and brain synchronization. By using this innovative device, EBS aims to achieve neurological recovery that leads to a normalization of vision and speech deficits. The process includes measurements of each patient´s EEG patterns for individual frequency and current strength customization, and uses pulsed electrical stimulations of low-currents, which are applied by electrodes. A prototype has been tested in clinical trials, with more than 1,000 patients in observational studies, for example, at the Charité University Hospital in Berlin. EBS NEXT WAVE™ is expected to launch in the German market in the first quarter of 2012, after receiving the European Commission’s CE certification for meeting the EU safety, health, and environmental protection standards.
For more information, visit www.ebstech.de